In 2021, a merger occurred between dMed, a Chinese Clinical Research Organisation (CRO) serving a predominantly Chinese audience, and Clinipace, a US-headquartered CRO serving a global audience.
As a result of the merger, the company needed to have an entirely new brand to go to market with, providing a clear articulation of how and why it offered something valuable and distinct.
A clear brand identity and proposition that both internal and external stakeholders could believe in and champion was crucial to this project’s success.
It was also critical that the newly created brand was sensitive to the diverse cultural landscape of the audience, respecting and reflecting the legacy brands.
Due to the contrasting cultures that were coming together for this project, it was a complex process when it came to the brand-naming project. Cultural and linguistic considerations had to be factored in to ensure a seamless cultural blend, meaning all potential names needed to be validated in Chinese characters. Even though our focus was on the ‘invented’ naming territory, when translated into Mandarin, each syllable had its own meaning.
Brand color palettes and iconography were also not only developed in accordance with the brand personality and competitor set in mind, they were also carefully considered to ensure they had the desired meaning to all cultures globally.
To bring dMed and Clinipace together, we undertook:
For Caidya’s launch, we:
Analysis one-month post-launch showed a successful campaign that demonstrated the accuracy of Caidya’s new messaging in generating those crucial high-value leads.
organic clicks to the site
CPM during launch display campaign
conversions in the website’s first month
Insights, ideas and impact for every milestone.
Starting with your objectives and working backward, we set milestones to incrementally realize your vision, advising you on the best strategy to employ and executing tactics that will drive you toward your goals.